On 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...
Read moreThe changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...
Read moreThe report looks at four possible scenarios including most notably the creation of a “grande Sécu...
Read moreThe association proposes concentrating efforts around four primary objectives.
Read moreIn addition to new cancer drugs, the G-BA also evaluated the first antiviral drug to treat COVID-19 ...
Read moreNotably, the early access scheme was reformed with effect from 1st July 2021.
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreThe introduction of new medicines in England requires the cooperation of industry and the NHS.
Read moreICER recently outlined its plans to annually assess Barriers to Fair Access within prescription drug...
Read more